Wagner Wealth Management (South Carolina)’s Moderna MRNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-98
Closed -$12K 535
2022
Q3
$12K Sell
98
-2
-2% -$303 0.01% 402
2022
Q2
$14K Buy
+100
New +$14.3K 0.01% 388
2022
Q1
Sell
-111
Closed -$28K 487
2021
Q4
$28K Hold
111
0.02% 341
2021
Q3
$38K Buy
111
+13
+13% +$4.79K 0.03% 277
2021
Q2
$23K Hold
98
0.02% 364
2021
Q1
$13K Buy
+98
New +$14.2K 0.01% 428

Other funds holding MRNA

Wagner Wealth Management (South Carolina)'s MRNA Position: Q4 2022 in Review

Wagner Wealth Management (South Carolina) sold out of Moderna (MRNA) in Q4 2022, closing a stake of 98 shares — an estimated $12K sold.

Wagner Wealth Management (South Carolina) first reported a position in MRNA in Q1 2021 and held it in 6 quarters. The position peaked at $38K in Q3 2021. 1,072 funds tracked by Wall St. Rank hold MRNA as of Q4 2022.

  • Wagner Wealth Management (South Carolina) reported no remaining Moderna position as of Q4 2022 after selling out during the quarter.
  • Wagner Wealth Management (South Carolina) sold 98 Moderna shares in Q4 2022, an estimated $12K.
  • Wagner Wealth Management (South Carolina) first reported a position in Moderna in Q1 2021 and held it in 6 quarters.
  • Wagner Wealth Management (South Carolina)'s Moderna position peaked at $38K in Q3 2021.
  • 1,072 funds tracked by Wall St. Rank held Moderna as of Q4 2022.

Based on Wagner Wealth Management (South Carolina)'s 13F filing for Q4 2022, filed 14 Feb 2023.